Cargando…
A new era in aneuploidy screening: cfDNA testing in >30,000 multifetal gestations: Experience at one clinical laboratory
Since introducing cell-free DNA screening, Sequenom Laboratories has analyzed over 1 million clinical samples. More than 30,000 of these samples were from multifetal gestations (including twins, triplets and higher-order multiples). The clinical laboratory experience with the first 30,000 multifetal...
Autores principales: | Dyr, Brittany, Boomer, Theresa, Almasri, Eyad A., Wardrop, Jenna L., Rafalko, Jill, Chibuk, Jason, McCullough, Ron M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687285/ https://www.ncbi.nlm.nih.gov/pubmed/31393959 http://dx.doi.org/10.1371/journal.pone.0220979 |
Ejemplares similares
-
Three years of clinical experience with a genome-wide cfDNA screening test for aneuploidies and copy-number variants
por: Soster, Erica, et al.
Publicado: (2021) -
Impact of mosaicism ratio on positive predictive value of cfDNA screening
por: Rafalko, Jill M., et al.
Publicado: (2020) -
Positive cfDNA screening results for 22q11.2 deletion syndrome—Clinical and laboratory considerations
por: Soster, Erica, et al.
Publicado: (2023) -
Application of mosaicism ratio to multifetal gestations
por: Rafalko, Jill, et al.
Publicado: (2021) -
Cell‐free DNA screening in twin pregnancies: A more accurate and reliable screening tool
por: Chibuk, Jason, et al.
Publicado: (2020)